XML 24 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Parent
Cumulative Effect of Adoption
Parent
As Adjusted Balance
Parent
Common Stock
As Adjusted Balance
Common Stock
Capital in Excess of Par Value
As Adjusted Balance
Capital in Excess of Par Value
Cumulative Net Income
Cumulative Effect of Adoption
Cumulative Net Income
As Adjusted Balance
Cumulative Net Income
Cumulative Distributions
As Adjusted Balance
Cumulative Distributions
Non-controlling Interests
As Adjusted Balance
Non-controlling Interests
Cumulative Effect of Adoption
As Adjusted Balance
Total
Balance at beginning of period at Dec. 31, 2017     $ 755,160   $ 396   $ 856,992     $ 1,100,783   $ (1,203,011)   $ 3,488     $ 758,648
Balance (in shares) at Dec. 31, 2017         39,570                        
Equity activity                                  
Issuance of common stock     929       929                   929
Issuance of common stock (in shares)         22                        
Issuance of restricted stock     (8)   $ 1   (9)                   (8)
Issuance of restricted stock (in shares)         91                        
Net income     154,981             154,981       95     155,076
Stock-based compensation expense     5,870       5,870                   5,870
Stock option exercises     123       123                   123
Stock option exercises (in shares)         5                        
Non-controlling interests contributions                           3,963     3,963
Non-controlling interest distributions                           (65)     (65)
Common stock cash distributions     (90,372)                 (90,372)         (90,372)
Other     (1,193)       (1,193)                   (1,193)
Other (in shares)         (31)                        
Balance at end of period at Dec. 31, 2018     825,490   $ 397   862,712     1,255,764   (1,293,383)   7,481     832,971
Balance (in shares) at Dec. 31, 2018         39,657                        
Equity activity                                  
Issuance of restricted stock     (7)       (7)                   (7)
Issuance of restricted stock (in shares)         86                        
Net income     80,526             80,526       346     80,872
Stock-based compensation expense     6,566       6,566                   6,566
Vesting of performance-based stock units     (301)                 (301)         (301)
Vesting of performance-based stock units (in shares)         48                        
Stock option exercises     123   $ 1   122                   123
Stock option exercises (in shares)         5                        
Non-controlling interests contributions                           965     965
Non-controlling interest distributions                           (309)     (309)
Common stock cash distributions     (90,599)                 (90,599)         (90,599)
Other     (2,047)       (2,047)                   (2,047)
Other (in shares)         (44)                        
Balance at end of period at Dec. 31, 2019 $ (42,808) $ 782,682 776,943 $ 397 $ 398 $ 862,712 867,346 $ (42,808) $ 1,212,956 1,293,482 $ (1,293,383) (1,384,283) $ 7,481 8,483 $ (42,808) $ 790,163 785,426
Balance (in shares) at Dec. 31, 2019       39,657 39,752                        
Equity activity                                  
Repurchase of common stock     (18,012)   $ (6)   (18,006)                   (18,012)
Repurchase of common stock (in shares)         (616)                        
Issuance of restricted stock     (8)   $ 1   (9)                   (8)
Issuance of restricted stock (in shares)         101                        
Net income     95,293             95,293       384     95,677
Stock-based compensation expense     7,012       7,012                   7,012
Vesting of performance-based stock units     (586)                 (586)         (586)
Vesting of performance-based stock units (in shares)         82                        
Non-controlling interest distributions                           (463)     (463)
Common stock cash distributions     (89,676)                 (89,676)         (89,676)
Other     (3,564)   $ (1)   (3,563)                   (3,564)
Other (in shares)         (77)                        
Balance at end of period at Dec. 31, 2020     $ 767,402   $ 392   $ 852,780     $ 1,388,775   $ (1,474,545)   $ 8,404     $ 775,806
Balance (in shares) at Dec. 31, 2020         39,242